However, despite these beneficial consequences, a longitudinal assessment of HD-associated phenotypes from four weeks of age revealed that KMO ablation had no effect on the extent or progression of weight loss, grip strength impairment, rotarod performance or locomotor activity. This evidence concerns the gene KMO and Huntington disease.